Copy number variability in Parkinson’s disease: assembling the puzzle through a systems biology approach

Abstract

Parkinson’s disease (PD), the second most common progressive neurodegenerative disorder of aging, was long believed to be a non-genetic sporadic origin syndrome. The proof that several genetic loci are responsible for rare Mendelian forms has represented a revolutionary breakthrough, enabling to reveal molecular mechanisms underlying this debilitating still incurable condition. While single nucleotide polymorphisms (SNPs) and small indels constitute the most commonly investigated DNA variations accounting for only a limited number of PD cases, larger genomic molecular rearrangements have emerged as significant PD-causing mutations, including submicroscopic Copy Number Variations (CNVs). CNVs constitute a prevalent source of genomic variations and substantially participate in each individual’s genomic makeup and phenotypic outcome. However, the majority of genetic studies have focused their attention on single candidate-gene mutations or on common variants reaching a significant statistical level of acceptance. This gene-centric approach is insufficient to uncover the genetic background of polygenic multifactorial disorders like PD, and potentially masks rare individual CNVs that all together might contribute to disease development or progression. In this review, we will discuss literature and bioinformatic data describing the involvement of CNVs on PD pathobiology. We will analyze the most frequent copy number changes in familiar PD genes and provide a “systems biology” overview of rare individual rearrangements that could functionally act on commonly deregulated molecular pathways. Assessing the global genome-wide burden of CNVs in PD patients may reveal new disease-related molecular mechanisms, and open the window to a new possible genetic scenario in the unsolved PD puzzle.Electronic supplementary materialThe online version of this article (doi:10.1007/s00439-016-1749-4) contains supplementary material, which is available to authorized users.

Chronic Systemic Inflammation Exacerbates Neurotoxicity in a Parkinson’s Disease Model

“…Despite the amount of research on this neurodegenerative disease, its origin remains unclear. Only 5-10% of cases have a genetic background [2][3][4][5], while the rest are of idiopathic origin [6], although some risk factors have been identified, such as age, environmental toxins, and infections [7,8].…”

3D brain Organoids derived from pluripotent stem cells: promising experimental models for brain development and neurodegenerative disorders

“…In recent years, genomic studies of individuals with developmental or neurodegenerative diseases have tremendously advanced our understanding of the genetics of these disorders [ 1 – 5 ]. Many of them, including autism spectrum disorder (ASD), schizophrenia, Alzheimer’s disease (AD), and Parkinson’s disease (PD), are caused by a heterogeneous combination of variant alleles and have therefore proven difficult to recapitulate in animal models, which are better suited for studying single-gene mutations [ 6 – 9 ]. Although the human brain is the ideal model to study human neuropathology, the limited availability of healthy and diseased brain tissue as well as the difficulties with culturing or genetically manipulating the tissue makes this an inopportune model with which to easily elucidate molecular mechanisms underlying these disorders.…”

Replication‐Based Rearrangements Are a Common Mechanism for SNCA Duplication in Parkinson's Disease

“…It has been reported that multiplications of SNCA are observed in around 0.05% of European PD patient populations . Other genes related to hereditary forms of PD have copy number variations (CNVs) demonstrating the role of loss of function . CNVs in SNCA , however, seem to suggest a gain of function.…”